Home - Products - Others - Other Targets - [Val3]-β-Casomorphin (1-4) amide (bovine)

[Val3]-β-Casomorphin (1-4) amide (bovine)

CAS No. ———

[Val3]-β-Casomorphin (1-4) amide (bovine)( ——— )

Catalog No. M40955 CAS No. ———

[Val3]-β-Casomorphin (1-4) amide (bovine)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    [Val3]-β-Casomorphin (1-4) amide (bovine)
  • Note
    Research use only, not for human use.
  • Brief Description
    [Val3]-β-Casomorphin (1-4) amide (bovine)
  • Description
    [Val3]-β-Casomorphin (1-4) amide (bovine)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    473.58
  • Molecular Formula
    C24H35N5O5
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • KL-50

    KL-50 is a selective toxin toward tumors that lack the DNA repair protein O6-methylguanine-DNA-methyltransferase (MGMT), which reverses the formation of O6-alkylguanine lesions. KL-50 activates DNA damage response pathways and cycle arrest in MGMT-cells, independent of mismatch repair (MMR). KL-50 is promising for research of brain tumors that lack the DNA repair protein MGMT.

  • Acetylcimigenol 3-O-...

    Acetylshengmanol Arabinoside is isolated from Cimicifugae rhizoma.

  • Glaucine

    Glaucine has antitussive antioxidative potential and antiviral activities it may be an anti-arthritic agent it can enhance LPS and zymosan-induced IL-10 production. Glaucine can inhibit the migration and invasion of human breast cancer cells by MMP-9 inhibitory activity attenuating IκBα and NF-κB activities.